Ropivacaine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ropivacaine Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Ropivacaine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 16 USDMF, 12 CEP/COS, 1 JDMF, 12 EU WC, 5 KDMF, 12 NDC API, 35 Listed Suppliers, $ API Reference Price

49 API Suppliers
16 USDMF
12 CEP/COS
1 JDMF
12 EU WC
5 KDMF
12 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

158 FDF Dossiers, 75 FDA Orange Book, 48 Europe, 6 Canada, 7 South Africa, 22 Listed Dossiers

158 FDF Dossiers
75 FDA Orange Book
48 Europe
6 Canada
7 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - 100MG/10ML (10MG/ML), SOLUTION;INJECTION - 100MG/20ML (5MG/ML), SOLUTION;INJECTION - 150MG/30ML (5MG/ML), SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML), SOLUTION;INJECTION - 1GM/200ML (5MG/ML), SOLUTION;INJECTION - 200MG/20ML (10MG/ML), SOLUTION;INJECTION - 200MG/100ML (2MG/ML), SOLUTION;INJECTION - 20MG/10ML (2MG/ML), SOLUTION;INJECTION - 400MG/200ML (2MG/ML), SOLUTION;INJECTION - 40MG/20ML (2MG/ML), SOLUTION;INJECTION - 500MG/100ML (5MG/ML), SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INJECTION - 100MG/10ML (10MG/ML)
SOLUTION;INJECTION - 100MG/20ML (5MG/ML)
SOLUTION;INJECTION - 150MG/30ML (5MG/ML)
SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)
SOLUTION;INJECTION - 1GM/200ML (5MG/ML)
SOLUTION;INJECTION - 200MG/20ML (10MG/ML)
SOLUTION;INJECTION - 200MG/100ML (2MG/ML)
SOLUTION;INJECTION - 20MG/10ML (2MG/ML)
SOLUTION;INJECTION - 400MG/200ML (2MG/ML)
SOLUTION;INJECTION - 40MG/20ML (2MG/ML)
SOLUTION;INJECTION - 500MG/100ML (5MG/ML)
SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Actylis

3 Actylis

DIGITAL CONTENT

29 News #PharmaBuzz

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Regulatory FDF Prices

1 US Medicaid Prescriptions
25 Regulatory FDF Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 14 Health Canada Patents

4 US Patents
14 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 15 Others

3 EDQM
3 USP
15 Others

$ API Ref.Price (USD/KG) : 1,378 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4FRESENIUS KABI USA

filter Patent Number Reset all filters

4 All

01 27828787

02 27857802

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 22025-10-18

02 22026-11-28

Chemwerth Ropivacaine HCl

Product Main Page

01

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

FRESENIUS KABI USA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-28

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

FRESENIUS KABI USA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-18

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

FRESENIUS KABI USA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-18

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

FRESENIUS KABI USA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-28

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!